TruCap Finance has initiated a postal ballot to secure shareholder approval for raising up to Rs 58 crore via equity or convertible securities. The company is also proposing the 'Dhanvarsha ESOP Plan 2026', allocating 1.75 crore stock options to employees and subsidiary staff. These actions are being conducted under the shadow of a pending open offer from Marwadi Chandarana Intermediaries, necessitating explicit shareholder consent for capital structure changes.
TruCap Finance Seeks Shareholder Nod for Rs 58 Crore Fundraise and ESOP Plan
TruCap Finance aims to raise up to Rs 58 crore through equity or convertible securities.
The company is simultaneously proposing a new ESOP pool consisting of 1.75 crore stock options.
Reader Takeaway: Growth capital and employee incentives are on the table, but the ongoing SAT-contested open offer introduces significant regulatory friction.
What just happened
TruCap Finance has launched a postal ballot process seeking shareholder approval for four primary resolutions. The board is looking to raise up to Rs 58 crore through the issuance of equity shares or convertible securities. Additionally, the company has proposed the 'Dhanvarsha ESOP Plan 2026', which includes a pool of 1.75 crore stock options, each convertible into a equity share of Rs 2 face value. This plan extends eligibility to employees and directors of subsidiary firms.
Why this matters
The company is currently constrained by a subsisting open offer initiated by Marwadi Chandarana Intermediaries Brokers Private Limited (MCIBPL) in May 2025. Under SEBI’s Takeover Regulations, the company is prohibited from altering its capital structure without explicit shareholder approval during an open offer period. This postal ballot is a procedural necessity to bypass those restrictions and proceed with the proposed capital infusion and incentive schemes.
The backstory
The open offer by MCIBPL remains a complex legal situation. Despite the acquirer attempting to withdraw the offer, SEBI directed them to comply with the process. The matter is currently being litigated at the Securities Appellate Tribunal (SAT), and the offer remains legally active, creating a backdrop of regulatory uncertainty for all proposed corporate actions.
Risks to watch
The primary risk remains the ongoing SAT proceedings. Any regulatory directive from SEBI or a ruling by the tribunal could potentially delay or invalidate the current plans for fundraising and ESOP issuance. Investors should also monitor the execution timeline, as these capital structure changes are contingent on successfully passing special resolutions during the voting window ending December 3, 2026.
What to track next
Shareholders have until December 3, 2026, to cast their votes. The final results of the postal ballot are expected to be announced on or before December 7, 2026.
